Gene: NEK1
Official Full Name: NIMA related kinase 1provided by HGNC
Gene Summary: The protein encoded by this gene is a serine/threonine kinase involved in cell cycle regulation. The encoded protein is found in a centrosomal complex with FEZ1, a neuronal protein that plays a role in axonal development. Defects in this gene are a cause of polycystic kidney disease (PKD). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07232 | NEK1 Knockout cell line (HeLa) | Human | NEK1 | 1:3~1:6 | Negative | Online Inquiry |
KO07233 | NEK1 Knockout cell line (HCT 116) | Human | NEK1 | 1:2~1:4 | Negative | Online Inquiry |
KO07234 | NEK1 Knockout cell line (HEK293) | Human | NEK1 | 1:3~1:6 | Negative | Online Inquiry |
KO07235 | NEK1 Knockout cell line (A549) | Human | NEK1 | 1:3~1:4 | Negative | Online Inquiry |
NEK1 Gene Knockout Cell Lines are genetically engineered cell lines created to lack the expression of the NEK1 (NIMA-related kinase 1) gene. NEK1 is known to play a vital role in various cellular processes including cell division, response to DNA damage, and regulation of the cell cycle. By developing knockout variants, researchers can effectively study the functions of NEK1, providing a deeper understanding of its role in cellular processes and its implications in disease states.
These cell lines utilize CRISPR-Cas9 technology to achieve specific gene disruption, which allows for the precise ablation of NEK1 activity. The knockout mechanism introduces insertions or deletions (indels) in the NEK1 gene sequence, ultimately leading to a non-functional protein. This robust approach enables biologists to interrogate the consequences of NEK1 loss on cellular growth, apoptosis, and stress response pathways, thereby enhancing our understanding of diseases such as cancer and neurodegeneration where NEK1 is implicated.
The significance of NEK1 Gene Knockout Cell Lines extends to both basic and translational research settings. In fundamental studies, these lines are invaluable for dissecting the molecular pathways regulated by NEK1. Clinically, they offer the potential to inform therapeutic strategies aimed at conditions related to NEK1 dysregulation. Moreover, the utility of these cell lines in drug screening assays promotes the identification of novel pharmacological agents targeting related pathways.
Compared to traditional methods of gene editing, our NEK1 Gene Knockout Cell Lines provide distinct advantages such as enhanced specificity and efficiency, facilitating a more streamlined experimental design. Their straightforward application allows researchers to generate reproducible and reliable data, removing barriers associated with inconsistent results often seen in conventional techniques.
For researchers and clinicians, the value of NEK1 Gene Knockout Cell Lines lies in their ability to support high-impact discoveries that can lead to innovative therapeutic interventions. With a commitment to advancing scientific understanding, our company specializes in cutting-edge genetic tools that empower the research community, ensuring that our products remain at the forefront of biological investigation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.